Gordon Freeman
North America, California, United States
Description
Gordon Freeman is a Scientific Co-Founder of NextPoint Therapeutics.
Investor Profile
Gordon Freeman has made 2 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
